Metformin and Vitamin D Modulate Inflammation and Autophagy during Adipose-Derived Stem Cell Differentiation

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Metabolic Disease Research

Background:

• Adipose-derived stem cells (ADSCs) are crucial for tissue regeneration but their dysregulation in adipogenesis links to inflammation, insulin resistance, and obesity.
• Chronic low-grade inflammation and macrophage infiltration in adipose tissue are associated with metabolic disorders.

Purpose of the Study:

• To investigate the effects of metformin and vitamin D, individually and combined, on inflammation and autophagy in ADSCs during adipogenic differentiation.
• To assess the potential of these compounds in managing obesity and related metabolic conditions.

Main Methods:

• ADSCs were cultured in adipogenic medium with metformin, vitamin D, or both for 21 days.
• Analyzed gene/protein expression (FoxO1, HSPs, ATG12, LC3B I/II) and cytokine secretion (IL-6, TNF-α) using ELISA and Western blot.

Main Results:

• Metformin and vitamin D modulated adipogenic differentiation, inflammatory response, and autophagy in ADSCs.
• Observed changes in Heat Shock Protein (HSP) mRNA levels and significant downregulation of pro-inflammatory cytokine secretion (IL-6, TNF-α).

Conclusions:

• Metformin and vitamin D show potential in fine-tuning the inflammatory response and autophagy during adipogenesis.
• These findings suggest therapeutic applications for preventing obesity and associated metabolic disorders by controlling lipogenesis.